Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 16/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 13/20 | 0.45 |
| ▸ | KIF11 | P52732 | 1/20 | 0.45 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13156763 | 0.86 | PDE3B (0.37) | — | |
| SCHEMBL10091341 | 0.82 | ESR2 (0.42) | ESR1ESR2APPCYP3A4CYP2C9 | |
| SCHEMBL21771748 | 0.81 | AKR1C3 (0.39) | — | |
| SCHEMBL14074141 | 0.81 | PDE3B (0.42) | ESR1ESR2 | |
| SCHEMBL14648802 | 0.81 | CYP11B1 (0.43) | ESR2APPCYP2C19 | |
| SCHEMBL1513346 | 0.80 | ESR2 (0.55) | ESR1ESR2KIF11 | |
| SCHEMBL18069656 | 0.79 | AKR1C3 (0.42) | — | |
| SCHEMBL20012960 | 0.78 | RARB (0.41) | — | |
| SCHEMBL18069660 | 0.78 | AKR1C3 (0.42) | ESR1ESR2 | |
| SCHEMBL14172915 | 0.78 | ESR2 (0.50) | ESR1ESR2KIF11APPCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8652353-B2 | Liquid crystal carbonate and liquid crystal medium containing the same with positive or negative dielectric anisotropy | WOJSKOWA AKADEMIA TECHNICZNA (PL) | 2014-02-18 | — | — | US | disclosed |
| US-20130020532-A1 | Liquid crystal carbonate and liquid crystal medium containing the same with positive or negative dielectric anisotropy | WOJSKOWA AKADEMIA TECHNICZNA (PL) | 2013-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130020532-A1 | Liquid crystal carbonate and liquid crystal medium containing the same with positive or negative dielectric anisotropy | HCN2, HCN3, HCN1 | ESR1 1357/4885ESR2 2206/4885KIF11 1613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.